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Abstract 
 
 
Objective - Thiol isomerases facilitate protein folding in the endoplasmic reticulum, and 
several of these enzymes, including PDI and ERp57, are mobilized to the surface of 
activated platelets, where they influence platelet aggregation, blood coagulation and 
thrombus formation.   
In this study we examined for the first time the synthesis and trafficking of thiol 
isomerases in megakaryocytes, determined their subcellular localization in platelets and  
identified the cellular events responsible for their movement to the platelet surface upon 
activation.  
 
Approach and Results – Immunofluorescence microscopy (IFM) imaging was used to 
localize PDI and ERp57 in murine and human megakaryocytes at various developmental 
stages. IFM and subcellular fractionation analysis were used to localize these proteins in 
platelets to a compartment distinct from known secretory vesicles that overlaps with an 
inner cell surface membrane region defined by the endoplasmic/sarcoplasmic reticulum 
proteins calnexin and SERCA3. IFM and flow cytometry were used to monitor thiol 
isomerase mobilization in activated platelets in the presence and absence of actin 
polymerization (inhibited by latrunculin), and in the presence or absence of membrane 
fusion mediated by Munc 13-4 (absent in platelets from Unc13dJinx mice).  
 
Conclusions – Platelet-borne thiol isomerases are trafficked independently of secretory 
granule contents in megakaryocytes, and become concentrated in a subcellular 
compartment near the inner surface of the platelet outer membrane corresponding to the 
sarco/endoplasmic reticulum of these cells. Thiol isomerases are mobilized to the 
surface of activated platelets via a process that requires actin polymerization but not 
SNARE/Munc 13-4-dependent vesicular-plasma membrane fusion. 
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Nonstandard Abbreviations and Acronyms 
PDI= protein disulfide isomerase 
ER= endoplasmic reticulum 
MK= megakaryocyte 
DTS= dense tubular system 
SNAREs= soluble N-ethylmaleimide-sensitive fusion protein attachment receptors 
MVBs= multivesicular bodies  
TFR= Transferrin receptor  
VWF= Von Willebrand factor  
TSP-1= thrombospondin-1  
PF4= Platelet Factor 4 
RabGDI= Rab GDP Dissociation Inhibitor 
SERCA3 = sarco/endoplasmic reticulum calcium ATPase 3. 
TLR9= toll-like receptor 9  
WT= wild type 
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Introduction 
 
Thiol isomerases facilitate the reduction, oxidation and rearrangement of disulfide bonds 
essential for correct folding of secreted proteins in the endoplasmic reticulum (ER).1, 2 
Some cells also have thiol isomerases in granular structures3 or at the cell surface,4, 5 
and in platelets protein disulfide isomerase (PDI), ERp57 and other thiol isomerases are 
mobilized to the cell surface with procoagulant activation. Inhibition of platelet-borne thiol 
isomerases reduces aggregation, granule secretion, receptor activation and thrombus 
formation in vitro and in vivo. 3, 4, 6-11 As with platelets, release of thiol isomerases by 
vascular endothelial cells has been linked to de-encryption of tissue factor, fibrin 
formation10, 12, 13 and neutrophil recruitment to the vessel wall during inflammation.8, 14  
 
Elucidating the role of thiol isomerases in platelet function, blood coagulation and 
thrombus formation requires understanding how they are packaged and mobilized.6, 8, 10, 
15-19 In this study we tracked PDI and ERp57 through development of precursor 
megakaryocytes (MK) and platelets, where we observed that these enzymes are 
concentrated in a subcellular compartment distinct from known secretory vesicles that 
overlaps with the dense tubular system (DTS) derived from MK smooth ER, and with the 
inner surface of the platelet outer membrane where the sarco/endoplasmic reticulum 
calcium ATPase SERCA3 is known to be localized.20 During platelet activation, actin 
polymerization facilitates the movement of secretory vesicles to the cell plasma 
membrane surface,21 where the interaction of soluble N-ethylmaleimide-sensitive fusion 
protein attachment receptors (SNAREs) facilitates membrane fusion mediated by Munc 
13-4.22-26 We observed that surface mobilization of thiol isomerases within activated 
platelets also requires actin polymerization, but proceeds in the absence of Munc13-4-
mediated membrane fusion.  
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Material and Methods 
 
Materials and methods are available in the online-only Data Supplement 
 
Results   
 
Expression and distribution of PDI and ERp57 during MK development  
Unlike other mammalian cells, platelets are not derived from individual precursors via 
cell fission. Their development begins in the bone marrow with MK progenitors that 
undergo endomitosis to produce large cells (>20 μM diameter) with multi-lobed nuclei. 
Maturing MKs synthesize large amounts of proteins and develop elaborate intracellular 
membrane systems. The synthesized secretory cargo (e.g. Von Willebrand Factor, 
VWF) moves from the Golgi to multivesicular bodies (MVBs), where it is joined by 
endocytosed proteins (e.g. fibrinogen) prior to packaging in secretory granules. The 
platelet DTS is derived from MK smooth ER, while cell surface and open canalicular 
system (OCS) membranes originate in the MK demarcation membrane system (DMS), 
composed of flattened cisternae and tubules that develop by processes that involve 
dynamin 2-dependent endocytosis,27 surface membrane invagination and PACSIN2-
mediated membrane tubulation.28 MK development culminates in the production of 
proplatelet extensions that protrude into the vasculature and release hundreds or 
thousands of platelets from each cell into blood circulation.29 
We examined the intracellular distribution of PDI and ERp57 in developing cultured 
mouse MKs via high resolution immunofluorescence microscopy (IFM; Figure 1). MKs 
were identified by positive staining for CD41/integrin αIIb30 and staged by size, shape 
and nuclear morphology. In early (<10 μM diameter) and mitotic cells (Fig. 1A; Video 1) 
both thiol isomerases were extensively distributed through the cell, a pattern that 
persisted in later cells (i.e. synthetic cells; Fig.1B; Video 2), where ERp57 was 
sometimes concentrated in perinuclear ribbon-like structures (Fig.1B inset detail). Late-
stage cultured MKs typically flatten out prior to producing proplatelet extensions, and in 
these extending cells (Fig.1C; Video 3) both PDI and ERp57 were observed throughout 
the extranuclear region and in proplatelet extensions (Fig.1D; Video 4) including the 
terminal buds, where PDI appeared to be concentrated near the outer membrane. While 
throughout MK development colocalization of PDI and ERp57 was observed (white in 
merged images), substantial proportions of these proteins were not in the same 
locations. Similar subcellular distributions of these thiol isomerases were observed in 
cultured human MKs, where proplatelet development is not as readily observed (data not 
shown).  
 
MK trafficking of thiol isomerases is distinct from secretory granules and cargo 
Platelet secretory granule protein cargo is synthesized in the MK ER and transported via 
vesicles derived from the trans-Golgi network31 to early MVBs, which according to 
current models also receive cargo in endocytic vesicles as they mature and give rise to 
platelet lysosomes and  and dense32 granules.31, 33, 34 Transferrin receptor (TFR; CD71) 
undergoes clathrin-mediated endocytosis and is frequently used as marker of the MK 
recycling endocytic compartment,35 while TGN46 is a marker of the trans-Golgi network. 
IFM examination of thiol isomerase expression in human MKs in serum-free culture 
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revealed little overlap between ERp57, TFR and TGN46 (Figure 2 A; Video 5) or 
between PDI and the -granule cargo proteins VWF (Figure S1A; Video 6) and 
thrombospondin-1 (TSP-1; not shown). At no point did we observe thiol isomerases 
distributed in granular puncta (e.g. VWF in Figure S1A) or structures resembling MVBs, 
rather their distribution pattern was consistent with association with intracellular 
membranes. Thus our observations indicate that throughout MK and proplatelet 
development thiol isomerases are localized in a cellular compartment that is distinct from 
secretory granules and their cargo, and that these enzymes are likely associated with 
future platelet cell surface and/or non-granular membranes.  
 
The trafficking of thiol isomerases within MKs should determine their distribution within 
platelets. IFM observations showed consistent association of the α-granule membrane 
protein P-selectin with cargo proteins (e.g. VWF, Figure S1B) but not with PDI or ERp57 
(Figure 2B), which, as observed in MKs (Figure 1), partially overlap with each other 
(mean Pearson’s correlation coefficient = 0.6; sd = 0.08, n=12 cells). Similar 
relationships for PDI, ERp57 and P-selectin were observed in platelets from Nbeal2-/- 
mice lacking α-granules (Figure 2C), and thiol isomerase levels were similar in mouse 
and human platelets in the presence or absence of α-granules30, 36 (Figure 2D,E), further 
indicating their production and trafficking is independent of granules and their cargo.  
 
Platelet thiol isomerases are localized to a non-granular compartment near the cell 
surface membrane defined by overlap with SERCA3 
The association of thiol isomerases with platelet subcellular structures was investigated 
by fractionating cell lysates via sucrose gradient ultracentrifugation, and then probing 
fractions via immunoblotting for PDI, ERp57 and cell surface and interior membranes (β3 
integrin), proteins associated with cytosol (Rab GDP Dissociation Inhibitor; RabGDI), α –
granule cargo (TSP-1) and the DTS (calreticulin) (Figure 3A). As reported by 
Jonnalagadda et al37 β3 integrin  was present in the lighter fractions (2-3), but also 
abundant in the more dense fractions (8-10); corresponding to the plasma membrane 
and to the membrane of granules and endosomal compartments, respectively. The 
soluble cytosolic marker RabGDI was mainly concentrated at the top of the gradient as 
were the fractions containing calreticulin, a marker for the DTS previously used to detect 
PDI in this compartment in platelets.19 TSP-1 was abundantly expressed in the heaviest 
fractions where α –granules are fractionated. Consistent with our imaging and previous 
results,38 PDI and ERp57 were concentrated in the lightest fractions, indicating 
association with cell-surface and/or near-surface membrane structures such as the DTS.  
While fractionation might suggest the presence of thiol isomerases in the platelet 
cytosol, this is less likely because these proteins are expected to be targeted to the 
secretory system of cells by virtue of their ER retention motifs (PDI: KDEL, ERp57: 
QEDL).  
 
We examined the potential interaction of ERp57 with the DTS in human MK co-stained 
for calnexin, which like thiol isomerases promotes protein folding,39, 40 but observed little 
apparent association (Figure S2A; Video 7). In platelets we observed that calnexin is 
associated with well-defined regions distinct from α-granules (Figure S2B) that likely 
represent the DTS, which showed partial overlap with ERp57 (Figure S2C), with most of 
the thiol isomerase detected outside the overlapping regions. Similar results were 
obtained (not shown) in colocalization analyses with other markers of the DTS (e.g. 
calreticulin), Golgi (e.g. TGN46) and endosomal compartments (e.g. EEA1), all of which 
were confined to intracellular locations distinct from those of thiol isomerases. 
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The sarcoplasmic/endoplasmic reticulum calcium ATPase SERCA3 is a well-studied 
regulator of platelet calcium loading that has been localized to the inner surface of the 
platelet outer membrane by cell fractionation, immunoprecipitation and IEM.20, 41 The 
main antibody employed in these studies was a mouse monoclonal (PL/IM430) raised 
against human platelet membranes that detects all 3 SERCA3 isoforms present in 
human platelets.41 Using the same antibody we examined the relationship of ERp57 with 
SERCA3 via IFM in human platelets, and the results (Figure 3B) show extensive overlap 
(mean Pearson’s correlation coefficient = 0.794; sd = 0.067, n=11 cells) in a 
compartment near the inner surface of the cell outer membrane delineated by the 
colocalization of these proteins (Figure 3, colocalization channel). Thus platelet thiol 
isomerase appears to be concentrated in a compartment that may overlap with the DTS 
and OCS, but is largely located near the inner cell surface.   
 
Platelet-borne PDI has been reported to associate with a T-granule system defined by 
toll-like receptor 9 (TLR9).18 We were unable to replicate this observation by IFM with 
the same anti-TLR9 antibody used in the original description of the T-granules (data not 
shown). Consistent with proteomics studies reporting low levels of TLR9 in platelets42, 43, 
we could not detect TLR9 in platelets by immunoblotting, and consequently, we did not 
further investigate the presence of thiol isomerases in putative T-granules.  
 
Mobilization of thiol isomerases to the platelet surface requires actin 
polymerization but not Munc 13-4-mediated membrane fusion 
The SERCA3 interaction partner STIM1 mobilizes to the surface of activated platelets 
via a process that is actin-dependent and associated with cytoskeletal and microdomain 
rearrangements, but is not thought to involve the fusion of vesicular and cell 
membranes.44 Like other platelet-borne thiol isomerases, PDI and ERp57 move to the 
surface upon activation,6, 17 as can be observed by IFM comparing their intracellular 
distribution with that of P-selectin (Figure S3A). We examined the role of actin 
polymerization in this process using latrunculin A, which prevents actin polymerization.45 
We determined that 200 M latrunculin A inhibits P-selectin mobilization in activated 
platelets by >50% (Figure S3B), and compared by IFM the intracellular/extracellular 
distributions of P-selectin and the α-granule borne protein VWF (Figure 4A) or of P-
selectin and thiol isomerases (Figure 4B), in platelets activated in the presence or 
absence of this concentration of latrunculin A. The results show that, in the absence of 
actin polymerization, platelets underwent little or no mobilization of PDI and ERp57 or of 
P-selectin and VWF, and retained a resting morphology indicated by flat shape and 
intact tubulin cytoskeletal ring. Using flow cytometry, we observed an increased surface 
expression of thiol isomerases, as reported previously 10, 17. Blocking actin 
polymerization with latrunculin A significantly inhibited the movement to the surface of 
both PDI and ERp57 (Figure 4C).  
 
When platelets are stimulated by agonists such as PAR4-activating peptide (PAR4-AP), 
Munc13-4 facilitates the pairing of SNAREs25, 26, 46 involved with the fusion of secretory 
vesicles with the cell surface membrane. ADP has also been observed to trigger 
Munc13-4-independent granule secretion.46 We investigated the role of Munc13-4-
dependent membrane fusion in platelet thiol isomerase mobilization using Unc13dJinx  
mice, which lack Munc13-4 activity but show equivalent expression to wild type (WT) of 
platelet thiol isomerases (Figure 5A). Flow cytometry assessment of surface expression 
of P-selectin and thiol isomerases in resting and agonist-stimulated platelets showed 
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that cells from Unc13dJinx mice had significantly less P-selectin surface expression than 
WT (Figure 5B) when stimulated with PAR4-AP, and there was partial rescue of 
response with ADP. When stimulated with PAR4-AP, Unc13dJinx platelets showed 
greater mobilization of PDI relative to WT (Figure 5B), and along with WT cells showed 
increased PDI mobilization in the presence of ADP. These results indicate that Munc13-
4-mediated membrane fusion events are not required for the mobilization/release of 
platelet thiol isomerases during activation, which may involve a mechanism similar to 
that proposed for STIM1.44    
 
Discussion 
 
In this study we began by tracing the synthesis, trafficking and packaging of platelet-
borne thiol isomerases in cultured primary human and murine MKs. The use of murine 
MKs allowed us to follow platelet development to the proplatelet extension stage, where 
nascent platelets are loaded with secretory granules and other organelles.47 This 
approach has proven effective in elucidating the origin of other platelet proteins such as 
glycosyltransferases.48 While human MKs derived from peripherally-mobilized CD34+ 
cells cultured under serum-free conditions do not develop proplatelets as readily as 
mouse cells, they have also proven useful in studies of the biogenesis of platelet 
granules.49 Their use was important to confirm that, as was expected, thiol isomerases 
destined for platelets are synthesized by MKs, since they are present in cells grown 
under serum-free conditions and show little evident association with endocytic pathways 
(Figure 2A).  
 
Our observations indicate that the bulk of MK ERp57 (and most likely PDI) synthesized 
by MKs is destined to become platelet cargo (Figure S2A), although we did observe an 
apparent transient strong association of ERp57 with the ER in mouse MKs undergoing 
peak protein synthesis (Figure 1B). Our observations also consistently indicate that the 
trafficking of thiol isomerases is distinct from -granule cargo proteins at all stages of MK 
development, in terms of cellular localization (Figure 1 A-D, Videos 1-4), distribution 
pattern (Figure S1A, Video 5) and interaction with the endocytic and trans-Golgi 
compartments (Figure 2A). This indicates that thiol isomerase destined for platelets is 
not trafficked through the MVBs that process granule-bound cargo. Rather their 
intracellular distribution indicates association with another of the many MK membrane 
systems, as has been proposed for platelet Golgi-derived glycosyltransferases.48 The 
membrane system associated with thiol isomerases appears to elaborate with 
proplatelet extensions (Figure 1D).   
 
In platelets, we observed that consistent with our MK observations PDI and ERp57 are 
localized in a subcellular compartment distinct from the -granule matrix delineated by 
P-selectin (Figure 2B). This is consistent with the reported lack of overlap between PDI 
and lysosomes50 or hyaluronidase-2 in human platelets, where the latter enzyme has 
been localized to -granules via IFM and subcellular fractionation.51 The thiol isomerase 
compartment appears to surround the P-selectin matrix (Figure 2B) and to be contained 
by the outer cell membrane (Figure 2C), a pattern that holds in GPS human and mouse 
Nbeal2-/- platelets where -granule cargo is absent (Figure 2C). The observation that -
granule cargo-deficient platelets have normal levels of thiol isomerases (Figure 2D,E) 
further supports the independence of their trafficking from granule cargo.  
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Our observations are consistent with reports of thiol isomerase located near the platelet 
surface6, 8, 10, 15-17 and DTS.19 We saw little association of ERp57 with smooth ER defined 
by calnexin in mature human MKs (Figure S2A), although we did observe localized 
overlap between this marker of the platelet DTS and ERp57 (Figure S2C). According to 
the most recent proteomics data ERp57 is approximately twice as abundant as calnexin 
in platelets (1736 vs. 890 ppm42), consistent with our observation that the thiol 
isomerase is more widely distributed in these cells (Figure S2C). Subcellular 
fractionation data indicate that in addition to the DTS, ERp57 and PDI are also likely 
associated with the cell surface membrane (Figure 3A). This expectation was confirmed 
by the observation of extensive overlap between ERp57 and SERCA3, long known to be 
located on the inner surface of the human platelet outer membrane (Figure 3B)20. In 
addition, ERp57 has been reported to interact with STIM152, a transmembrane ER 
protein that upon calcium depletion translocates to subplasmalemmal punctae where it 
interacts with the calcium channel Orai 1 located in the plasma membrane and allows 
calcium influx into the cell53. Given that as PDI and ERp57, SERCA 3 is an ER-derived 
protein20, 41, we cannot exclude the possibility that thiol isomerases co-distribute with 
SERCA 3 in a non-calnexin subpopulation of DTS (or possibly ER remnant) that is 
localized at the inner surface of the platelet membrane. 
The mobilization of thiol isomerases to the surface of activated platelets facilitates their 
involvement in clot formation,8-10 and studies have shown that PDI and ERp5 move to 
the platelet surface with similar kinetics to α-granule proteins.7 We have extended these 
observations by demonstrating that as with P-selectin and α-granule cargo,21 the 
mobilization of platelet thiol isomerases requires actin polymerization (Figure 4 and 
Table 1). Secretion by platelet granules also involves interactions between v-SNAREs 
present on their surface with t-SNAREs on the plasma membrane,54, 55 where membrane 
fusion is primed by Munc13-4, a limiting factor in platelet granule secretion.22-24, 26 We 
observed that compared to WT mice, platelet thiol isomerase mobilization is stronger in 
Unc13dJinx mice, where platelets lack Munc13-4 activity and have absent or severely 
impaired P-selectin mobilization (Figure 5B) and secretion from lysosomes and dense 
and α-granules, although they do show activation-associated changes in morphology.25 
We also observed that thiol isomerase mobilization is enhanced in both mutant and wild 
type mouse platelets by ADP, which has been shown to stimulate Munc13-4-
independent secretion of α-granule contents.46 Thus our observations indicate that while 
platelet thiol isomerase mobilization/secretion requires actin polymerization, it does not 
involve Munc13-4 mediated membrane fusion. It may be that the cellular 
rearrangements associated with platelet activation are sufficient to move thiol 
isomerases to the surface and facilitate their release, as has been proposed for STIM1.56 
Increased surface exposure of PDI in the absence of Munc 13-4 could also indicate that 
this protein serves as a brake on the mobilization of platelet thiol isomerases, pointing to 
a novel aspect of regulation of platelet function.  
The results presented here can be combined with current knowledge to produce a model 
of platelet thiol isomerase trafficking, packaging and mobilization in activated cells. In 
this scheme (Figure 6; for the sake of simplicity only MK-synthesized proteins are 
considered) protein destined for platelet α-granules (e.g. VWF, TSP-1) moves from the 
MK ER to the trans-Golgi network for sorting into MVBs that give rise to mature 
secretory vesicles. Following a different route, thiol isomerases destined for platelets 
move from the ER to the developing intracellular membranes. When MK extend 
proplatelets, secretory cargo is packaged into granules while thiol isomerases associate 
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with membranes that give rise to the platelet surface and possibly the outer DTS and 
OCS. In platelets that later undergo activation, thiol isomerases are mobilized to the 
outer cell surface via a mechanism driven by actin polymerization and 
cytoskeletal/membrane rearrangements.  
Elucidation of the expression and function of platelet thiol isomerases is important 
because these enzymes have been shown to be key modulators of thrombus formation 
via their activity on the surface of platelets and vascular endothelial cells. The influence 
of PDI, ERp57 and ERp5 on platelet function has been primarily attributed to their ability 
to bind the platelet cell surface receptor integrin αIIbβ3 and thus favor its activation,6-10 
and it is also likely that this receptor assumes a high-affinity conformation in activated 
platelets that facilitates surface binding of mobilized PDI and ERp57.57A search for other 
substrates of thiol isomerases is ongoing, as are efforts to develop methods for the 
selective modulation of thiol isomerases as a therapeutic strategy against thrombotic 
disease.58 
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Highlights 
 
 Platelet-borne thiol isomerases play important roles in hemostasis and in 
pathological thrombosis.  
 We examined for the first time the synthesis of thiol isomerases during 
megakaryocyte development showing that they are trafficked independently of 
granule cargo.   
 Within platelets thiol isomerases localize near the inner surface of the plasma 
membrane and partially overlap with the DTS 
 Thiol isomerases are released on the surface of activated platelets in an actin-
dependent process that does not require Munc13-4 mediated membrane fusion.  
 Defining the synthesis, trafficking, location and mechanism of 
mobilization/secretion of platelet thiol isomerases may aid the development of 
new antithrombotic strategies. 
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Figures 
 
 
 
Figure 1. Intracellular distribution of PDI and ERp57 during MK development.  IFM 
images (mid-cell Z-sections with YZ and XY profiles or extended focus renders) are 
shown for representative cultured mouse MK stained for ERp57 (magenta), PDI (green), 
CD41 (red) and DNA (blue; bars = 5µm except where noted). A) In early endomitotic 
cells ERp57 and PDI show a similar extranuclear distribution (see Video 1). B) In larger 
cells undergoing maximal protein synthesis PDI remains widely distributed, and in some 
cells ERp57 is highly concentrated in ribbon-like structures that may represent ER (inset 
detail bar = 1µm; see Video 2). C) As late-stage MKs flatten out, both thiol isomerases 
are present throughout the extranuclear region (see Video 3) and D) in proplatelet 
extensions (main cell body at right out of field), where they are present throughout the 
shafts and in terminal buds (see Video 4). 
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Figure 2. Thiol isomerases are not associated with MK trans-Golgi network or 
recycling endosomal compartments, or with platelet -granules.  A) IFM imaging of 
a representative mature human MK shows ERp57 (green) distributed throughout the cell 
having little overlap with trans-Golgi defined by TGN46 (red) or recycling endosomes 
containing TFR (magenta; mid-cell Z-section, bar = 10 µm). B) In a human platelet, PDI 
(green) and ERp57 (red) overlap with each other but not with P-selectin (magenta; mid-
cell Z-sections, bars = 1µm). C) Platelets stained for CD41/integrin αIIb (green), ERp57 
(red) and P-selectin (magenta) from WT and Nbeal2-/- mice (the latter lacking α-granule 
cargo) show similar intracellular distributions of thiol isomerase (mid-cell Z-sections, bars 
= 1 μM). D) Immunoblot analysis shows similar levels of PDI and ERp57 in WT and 
Nbeal2-/- mouse platelet lysates, and E) similar expression of PDI in lysates from normal 
human (NH) and Gray platelet syndrome (GPS) patient platelets (actin used as loading 
control). 
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Figure 3. Platelet thiol isomerases associate with cell-surface membrane 
structures and overlap with SERCA3 on the inner surface of the cell outer 
membrane. A) Human platelet lysates were fractionated by sucrose gradient and 
fractions (1-13) analyzed by immunoblotting for PDI, ERp57, β3 integrin, RabGDI b, 
TSP-1 and calreticulin (marker sizes in kilodaltons at left). Peak concentrations of PDI 
and ERp57 overlapped with β3 integrin corresponding to the cell surface membrane 
fraction, with cytosolic RabGDI b, and the DTS marker calreticulin and showed little 
overlap with -granule borne TSP-1 (Figure representative of 3 experiments). B) IFM 
imaging of fixed resting human platelets stained for ERp57 (green) and SERCA3 (red) 
shows overlap in a compartment defined by the latter on the inner surface of the cell 
outer membrane, delineated by the colocalization channel (yellow; mid-cell Z-sections, 
bars = 1 μM). 
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Figure 4. Mobilization of thiol isomerases in activated platelets requires actin 
polymerization. IFM imaging of human platelets activated with 4 μM U46619 in the 
presence (+LAT) or absence (-LAT) of latrunculin A, fixed and stained for tubulin 
(magenta), P-selectin (red) and either: A) CD42B/GP1b (light blue) and VWF (green), or 
B) PDI (light blue) and ERp57 (green). Reorganization of cytoskeletal tubulin and 
surface mobilization of P-selectin, VWF and ERp57 is evident in platelets not treated 
with latrunculin, while treated cells show intracellular protein distribution patterns similar 
to unactivated platelets (Fig.2B). Maximum intensity renders, bars = 1 μM. C) The effect 
of latrunculin treatment on the surface mobilization of thiol isomerases, as compared to 
that of P-selectin, was quantified by flow cytometry. Platelets were activated with 1U/ml 
of thrombin, the binding of the primary antibody for thiol isomerases was detected using 
a FITC-conjugated species-specific secondary antibody, the PE/Cy5 anti-human CD62P 
was used to detect P-selectin . The percentage of inhibition of the Median Fluorescence 
Intensity was calculated (**P<0.01, one-way ANOVA, followed by Dunnett’s test, n=3). 
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Figure 5. Surface mobilization of platelet thiol isomerase is independent of 
Munc13-4.  A) Immunoblot analysis of platelet lysates from wild type (WT) and 
Unc13dJinx  mice shows lack of Munc13-4 in the latter and similar levels of PDI and 
ERp57 (GAPDH loading control). B) Flow cytometry measurement of surface P-selectin 
(CD62P) and PDI in platelets under resting conditions or after stimulation with PAR4-AP 
in the presence/absence of ADP shows that P-selectin mobilization is significantly 
impaired in Unc13dJinx platelets but PDI mobilization is greater than WT. ADP 
significantly increased PDI mobilization as compared to WT or resting Unc13dJinx 
platelets (*P<0.05, *** P<0.001, one-way ANOVA, followed by Dunnett’s test or two-way 
ANOVA, followed by Bonferroni’s test, n=4). 
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Figure 6. Model comparing synthesis, trafficking, packaging and mobilization of 
-granule cargo.   
A) In the maturing MK, pro -granules (e.g. VWF, TSP-1) are trafficked 
from the ER via a pathway that leads through the trans-Golgi network to multivesicular 
bodies. B) Thiol isomerases associate with membranes destined for the platelet DTS 
and cell surface. C) As proplatelet extensions form secretory granule cargo is packaged, 
while thiol isomerases move with membranes into forming platelets. D) In mature 
platelets, thiol isomerases are concentrated near the surface membrane and in the near-
surface DTS. E) In activated platelets actin polymerization and membrane fusion 
facilitates the surface mobilization and secretion of granule cargo, while thiol isomerases 
mobilized without the need for membrane fusion. 
